FDA Adverse Event Malfunction Summary report: N

LIFEVEST WCD 4000 SYSTEM

MDR report key: 3941551 · Received April 17, 2014

Report

Report Number
3008642652-2014-01180
Event Type
Malfunction
Date Received
April 17, 2014
Date of Event
March 21, 2014
Report Date
April 14, 2014
Manufacturer
ZOLL LIFECOR CORPORATION
Product Code
MVK
PMA / PMN Number
P010030
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
BIOMEDICAL ENGINEER

Narratives

Additional Manufacturer Narrative · 1

DEVICE EVALUATION SUMMARY: DEVICE EVALUATION OF BATTERY CHARGER/MODEM SN (B)(4) HAS BEEN COMPLETED. AS RECEIVED, THE BATTERY CHARGER WOULD NOT POWER ON. THE CAUSE OF THE BATTERY CHARGER NOT POWERING ON WAS A FLASH MEMORY FAILURE (COMPONENTS U102 AND U105) ON THE COMPUTER/ANALOG BOARD. THE FLASH MEMORY HAD AN INTERMITTENT BGA CONNECTION, WHICH WAS DISCOVERED THROUGH THE USE OF A FLASH MEMORY TEST. THE INTERMITTENT CONNECTION IS LIKELY DUE TO A FRACTURED SOLDER CONNECTION INDUCED BY MECHANICAL STRESS. THE EXACT SOURCE OF THE MECHANICAL STRESS HAS NOT BEEN POSITIVELY IDENTIFIED BUT THE FRACTURED CONNECTION MAY HAVE BEEN ACCELERATED THROUGH ROUGH HANDLING. ROOT CAUSE ANALYSIS OF SIMILAR EVENTS FOUND THAT EXCESSIVE STRAIN ON THE PRINTED CIRCUIT ASSEMBLY (PCA) FROM SEVERE IMPACT CAN CAUSE FRACTURED SOLDER CONNECTIONS. A MECHANICAL DESIGN CHANGE TO REDUCE THE PCA STRAIN (B)(4) WAS APPROVED BY FDA ON 04/16/2013. IMPLEMENTATION BEGAN ON 05/09/2013. NO ADVERSE EVENT RESULTED FROM THE DEFECTIVE CHARGER/MODEM. THE LAST PATIENT TO USE THIS CHARGER/MODEM DID NOT REPORT ANY DEFICIENCIES.

Description of Event or Problem · 1

A REVIEW OF SERVICE DATA DETECTED A REPORTABLE EVENT. UPON SERVICE INVESTIGATION OF BATTERY CHARGER/MODEM SN (B)(4), THE BATTERY CHARGER WAS UNABLE TO POWER ON PROPERLY. THE LAST PATIENT TO USE THIS DEVICE DID NOT REPORT ANY DEFICIENCIES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
236502 LIFEVEST WCD 4000 SYSTEM WEARABLE CARDIOVERTER DEFIBRILLATPR MVK ZOLL LIFECOR CORPORATION WCD 4000 NA

Patients

Seq Age Sex Outcome Treatment
1 NA